Click here to view the programme of Session 1b

Chairs:
Myriam Chalabi, medical oncologist, NKI Amsterdam,
Min-Hee Ryu, medical oncologist, Seoul, Republic of Korea
Eric Van Cutsem, GI Oncologist, Leuven, Belgium

10:45 Immunotherapy in Stage IV Gastric Cancer
Samuel Cytryn, medical oncologist, Memorial Sloan Kettering, New York, USA

11:05 Perioperative Immunotherapy for locally advanced gastric and gastroesophageal junction cancers
Daisuke Takahari, vice director, Department of Medical Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan.

11:25 Improving response to immunotherapy
Sarah Derks, medical oncologist, Amsterdam UMC, Amsterdam, the Netherlands

11:45 Accepted oral abstract 01.1.4: Preoperative immunotherapy is associated with better pathological response in dMMR/MSI-H gastric cancer
Hong Zeng, Resident, Department of General Surgery, Zhongshan Hospital, Fudan University, China

11:55 Accepted oral abstract 01.1.5: IDO-1: A potential new target for immunotherapy in patients with Arid1a-deficient gastric cancer
Norbert Tay, Resident, Cancer Science Institute Of Singapore

12:05 Accepted oral abstract 01.1.6: Proteomic Analysis Predicts Therapeutic Outcomes of Neoadjuvant Chemo-immunotherapy in Gastric Cancer Patients
Hao Cui, Surgeon, The Chinese Pla General Hospital First Medical Center, China

12.15 –  End of session